Envisioning a Future Where Every Couple Has Access to Assisted Reproductive Technology – ESHRE
European Society of Human Reproduction and Embryology (ESHRE) shared a post on LinkedIn about a paper by Willem Ombelet et al. published on Human Reproduction Open:
“Assisted Reproductive Technology (ART) is an integral part of medicine.
Infertility is a major health problem – and access to health is a fundamental human right.
While ART may still be out of reach in many low-resource settings, it is essential to envision a future where every infertile couple, no matter where they live, has access to care.
The challenge is significant, but it is one worth taking on. The authors of this article call on all of us to join in shaping a more equitable future for reproductive medicine.”
Title: Now is the time to introduce new innovative assisted reproduction methods to implement accessible, affordable, and demonstrably successful advanced infertility services in resource-poor countries
Authors: Willem Ombelet, Jonathan Van Blerkom, Gerhard Boshoff, Carin Huyser, Federica Lopes, Geeta Nargund, Hassan Sallam, Koen Vanmechelen, Rudi Campo.
Read the full article.

-
Aug 3, 2026, 14:19Asmaa Khaled: The Success of IVF is Not Determined By the Number of Eggs Retrieved Alone…
-
Aug 3, 2026, 14:03Clare Mansfield: Sometimes the Path to Parenthood Changes, but the Dream Doesn’t Have To
-
Aug 3, 2026, 13:45Undiga Emuekpere: Basic Fertility Health Awareness Could Change Outcomes
-
Aug 3, 2026, 13:31Priyadatt Patel: A Quiet Inefficiency in How We Approach Infertility Deserves More Attention
-
Aug 3, 2026, 13:21Purabi Gunjal: Most Women Start Thinking about Fertility Too Late…
-
Aug 3, 2026, 13:10Juhee Jain: Empowering Women with the Right Information to Make Informed Decisions
-
Aug 3, 2026, 12:57Ashley Evans: Sometimes, the Thing that Got Me Through Fertility Treatment Wasn’t Positivity…
-
Aug 3, 2026, 12:42Devyanshi Dixit: Why Do the Best Healthcare Professionals Never Stop Learning?
-
Aug 3, 2026, 12:30Bringing Together the Brightest Minds in Reproductive Medicine for 3 Days at MEFS 2026
